Allylescaline

{{Short description|Psychedelic drug}}

{{chembox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 477348333

| ImageFile1 = Allylescaline.svg

| ImageSize1 = 200px

| ImageFile2 = Allylescaline-3d-sticks.png

| ImageSize2 = 200px

| PIN = 2-{3,5-Dimethoxy-4-[(prop-2-en-1-yl)oxy]phenyl}ethan-1-amine

| OtherNames = 2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethan-1-amine
2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethanamine

|Section1={{Chembox Identifiers

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = 21106254

| InChI = 1/C13H19NO3/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h4,8-9H,1,5-7,14H2,2-3H3

| InChIKey = JNUAYHHGCXYBHX-UHFFFAOYAR

| StdInChI_Ref = {{stdinchicite|changed|chemspider}}

| StdInChI = 1S/C13H19NO3/c1-4-7-17-13-11(15-2)8-10(5-6-14)9-12(13)16-3/h4,8-9H,1,5-7,14H2,2-3H3

| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}

| StdInChIKey = JNUAYHHGCXYBHX-UHFFFAOYSA-N

| CASNo_Ref = {{cascite|correct|CAS}}

| CASNo = 39201-75-7

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = J39IWS08EN

| ChEMBL_Ref = {{ebicite|changed|EBI}}

| ChEMBL = 126803

| PubChem = 44719469

| PubChem1 = 71669102

| PubChem1_Comment = hydrochloride

| SMILES = COc1cc(cc(OC)c1OCC=C)CCN

}}

|Section2={{Chembox Properties

| C=13

| H=19

| N=1

| O=3

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Allylescaline (4-allyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is closely related in structure to mescaline. Allylescaline was first synthesized by Otakar Leminger in 1972.{{cite journal|last=Leminger|first=Otakar|title=The Chemistry of Alkoxylated Phenethylamines – Part 2|journal=Chemický Průmysl|year=1972|volume=22|page=553|url=http://www.erowid.org/archive/rhodium/chemistry/leminger.html}} The compound was later synthesized by Alexander Shulgin and further described in his book PiHKAL.[http://www.erowid.org/library/books_online/pihkal/pihkal002.shtml AL Entry in PiHKAL] The dosage range is listed as 20–35 mg, and the duration 8–12 hours. Allylescaline produces an entactogenic warmth, an entheogenic effect, and a feeling of flowing energy. Very little data exists about the pharmacological properties, metabolism, and toxicity of allylescaline.